It was suggested that Indomethacin should be used cautiously when cancer pain occurred in patients with hepatocellular carcinoma to prevent recurrence and malignant metastasis of hepatocellular carcinoma caused by the down-regulation of TNF-alpha and IFN-gamma triggered by the over-use of Indomethacin. This evidence concerns the gene TNF and hepatocellular carcinoma.